2014 March
1. Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer. Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):E1301-10.
3. Impact of procedure volumes and focused practice on short-term outcomes of elective and urgent colon cancer resection in Italy. PLoS One. 2013 May 16;8(5):e64245.
4. Rapid isolation of cancer cells using microfluidic deterministic lateral displacement structure. Biomicrofluidics.2013 Jan;7(1): 011801.
5. Axillary lymph node biopsy in newly diagnosed invasive breast cancer: comparative accuracy of fine-needle aspiration biopsy versus core-needle biopsy. Radiology. 2013 Oct;269(1):54-60.
7. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology. 2013;84(2):100-7.
9. Digging deeper into the field of the small cell lung cancer tumor marker ProGRP: a method for differentiation of its isoforms. J Proteome Res. 2013 Jan 4;12(1):412-20.
11. HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases. PLoS One. 2013 Aug 13;8(8):e71611.
13. Bladder cancer-induced skeletal muscle wasting: disclosing the role of mitochondria plasticity. Int J Biochem Cell Biol. 2013 Jul;45(7):1399-409.
14. Nicotinamide phosphoribosyltransferase and SIRT3 expression are increased in well-differentiated thyroid carcinomas. Anticancer Res. 2013 Aug;33(8):3047-52.
17. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on Memorial Sloan-Kettering Cancer Center risk group stratification. Thyroid. 2013 Jun;23(6):683-94.
19. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer. BMC Cancer. 2013 Jan 17;13:24.
22. Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy. Gastric Cancer. 2013 Apr;16(2):233-8.
24. Extracts of Koelreuteria henryi Dummer induce apoptosis and autophagy by inhibiting dihydrodiol dehydrogenase, thus enhancing anticancer effects. Int J Mol Med. 2013 Sep;32(3):577-84.
26. Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results. Ann Oncol. 2013 Feb;24(2):398-405.
28. Role of ultrasound-guided transbronchial biopsy in the diagnosis of peripheral pulmonary lesions. Lung Cancer. 2013 Jul;81(1):60-4.
31. A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer. Cancer Chemother Pharmacol. 2013 May;71(5):1141-6.
2. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer. Int J Oncol. 2013 Mar;42(3):894-902.
6. Trends in smoking and lung cancer mortality in Japan, by birth cohort, 1949-2010. Bull World Health Organ. 2013 May 1;91(5):332-40.
8. Inhibition of p53 acetylation by PCAF inhibitor anacardic acid derivative in BCR-ABL1-expressing cells.; breaking resistance to DNA damage and possible therapeutical implications. Anticancer Agents Med Chem. 2013 Jun; 13(5):762-7.
10. Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery. Oncogene. 2013 Aug 15;32(33):3809-18.
12. Indirectly estimated absolute lung cancer mortality rates by smoking status and histological type based on a systematic review. BMC Cancer. 2013 Apr 9;13:189.
15. An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all. Int J Colorectal Dis. 2013 Oct;28(10):1377-84.
16. Quality of life after prostate cancer treatments in patients comparable at baseline. Br J Cancer. 2013 May 14;108(9):1784-9.
18. Clinical Outcome of Small Renal Cell Carcinoma after Delayed Surgery versus Immediate Surgery. J Cancer. 2013 Jul 19;4(6):514-8.
20. An update on molecularly targeted therapies in second- and third-line treatment in non-small cell lung cancer: focus on EGFR inhibitors and anti-angiogenic agents. Clin Transl Oncol. 2013 May;15(5):343-57.
21. GE132+Natural: Novel promising dietetic supplement with antiproliferative influence on prostate, colon, and breast cancer cells. J BUON. 2013 Apr-Jun;18(2):504-10.
23. Combined treatment with erlotinib and a transforming growth factor-β type I receptor inhibitor effectively suppresses the enhanced motility of erlotinib-resistant non-small-cell lung cancer cells. J Thorac Oncol. 2013 Mar;8(3):259-69.
25. Mineral-enriched deep-sea water inhibits the metastatic potential of human breast cancer cell lines. Int J Oncol. 2013 Nov;43(5):1691-700.
27. Expression of ADAM28 and IGFBP-3 genes in patients with colorectal cancer – a preliminary report. Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):223-8.
29. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models. Int J Oncol. 2012 Nov;41(5):1723-32.
30. Graphical identification of cancer-associated gene subnetworks based on small proteomics data sets. OMICS. 2013 Jul;17(7):393-7.